@misc{10481/90976,
year = {2015},
url = {https://hdl.handle.net/10481/90976},
abstract = {The implementation of hepatitis C (HCV) directacting antiviral drugs is prioritized in several populations in
which its application provides the most immediate and impactful benefit. In this scenario, a precise knowledge of the
situation of human immunodeficiency virus (HIV)/HCV
chronic co-infection is required to adequately address this disease. This cross-sectional study was performed in 21 hospitals
in Andalusia (Spain). The study population consisted of HIVinfected patients with an active HCV chronic infection who
were not receiving HCV treatment at the time of inclusion. A
total of 13,506 HIV-infected patients were included in the
study. Of them, 2561 (18.9 %) presented chronic HCV infection. The majority of the patients included were on highly
active antiretroviral therapy (HAART; 96.2 %), showed plasma levels with an undetectable HIV viral load (92.5 %), and
had a good immunological status (median CD4+ cell count of
486 cells/mL). The HCV genotype distribution was as follows: 58.1 % were genotype 1, 1.1 % were genotype 2},
title = {Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain},
doi = {10.1007/s10096-015-2476-9},
author = {Rivero-Juarez, Antonio and Gutierrez Valencia, A and Castaño, M and Merino, D and Neukam, K and Ríos Villegas, Maria Jose and López Ruz, Miguel Ángel and Jimenez Aguilar, P and Márquez, M and Collado, A and Gómez Vidal, A and Hernández Quero, José and Tellez, F and Fernández Fuertes, E and Rivero, A and López Cortes, LF},
}